Literature DB >> 17565154

Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.

David H Garfield, Aleck Hercbergs, Paul J Davis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17565154     DOI: 10.1093/jnci/djm008

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

1.  Management of hypothyroidism after radiotherapy for nasopharyngeal carcinoma.

Authors:  David H Garfield; Aleck Hercbergs; Paul Davis
Journal:  Med Oncol       Date:  2008-04-30       Impact factor: 3.064

2.  Thyroid hormone autoantibodies: are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments?

Authors:  P Mondello; M Mian; V Pitini; S Cuzzocrea; A Sindoni; M Galletti; M Mandolfino; D Santoro; S Mondello; C Aloisi; G Altavilla; S Benvenga
Journal:  Curr Oncol       Date:  2016-06-09       Impact factor: 3.677

3.  Endocrine sequelae of cancer and cancer treatments.

Authors:  Charles J Stava; Camilo Jimenez; Rena Vassilopoulou-Sellin
Journal:  J Cancer Surviv       Date:  2007-11-20       Impact factor: 4.442

Review 4.  Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy.

Authors:  Francesco Torino; Salvatore Maria Corsello; Raffaele Longo; Agnese Barnabei; Giampietro Gasparini
Journal:  Nat Rev Clin Oncol       Date:  2009-04       Impact factor: 66.675

5.  Atypical presentations and rare metastatic sites of renal cell carcinoma: a review of case reports.

Authors:  Petros Sountoulides; Linda Metaxa; Luca Cindolo
Journal:  J Med Case Rep       Date:  2011-09-02

6.  The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation.

Authors:  P Wolter; C Stefan; B Decallonne; H Dumez; M Bex; P Carmeliet; P Schöffski
Journal:  Br J Cancer       Date:  2008-08-05       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.